KSK-104
KSK-104 has potent antibacterial activity against Mycobacterium tuberculosis (MIC=0.78 μM) . The role of KSK-104 is mainly involved in the synthesis and recovery pathways of pyridoxal 5'-phosphate (PLP), PLP-dependent enzymes and oxidative stress networks. KSK-104, as a candidate molecule for novel anti-tuberculosis drugs, can be used to develop research against drug-resistant mycobacterium tuberculosis[1].
Product Specifications
UNSPSC
12352005
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/ksk-104.html
Smiles
O=C(NOCC(NOCC1=CC=CC=C1)=O)C2=CC=C(C=C2)C3=CC=CC=C3
Molecular Formula
C22H20N2O4
Molecular Weight
376.41
References & Citations
[1]Vill K, et al. α-Aminooxyacetic acid derivatives acting as pro-drugs against Mycobacterium tuberculosis[J]. bioRxiv, 2024: 2024.04. 04.587628.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Lentiviral human TNFSF14 shRNA (UAS) - Lentiviral human TNFSF14 shRNA (UAS, RFP) (100)
PSMB8 (Proteasome (Prosome, Macropain) Subunit, beta Type, 8 (Large multifunctional Peptidase 7), D6S216, D6S216E, LMP7, MGC1491, PSMB5i, RING10, beta5i) (HRP)
